Biotech firm alleges 'illegal' short-selling of stock

Article Abstract:

Hemispherx BioPharma alleged that the firm's stock is being undermined by unfavorable reports on the drug it is developing against chronic fatigue. The Philadelphia-based biotechnology firm said in its report to the Securities and Exchange Commission and the American and Nasdaq Stock Exchanges that the false report appeared in Business Week. A column in the Sept. 28, 1998 issue of the business magazine ran a quotation from investment banker and broker Manuel Asensio, which emphasized that the antiviral drug Ampligen is harmful, outdated and ineffective.

Comment:

Alleges that the firm's stock is being undermined by unfavorable reports on the drug it is developing against chronic fatigue

Pharmaceutical Preparation Manufacturing, Securities issued, listed, Antiinfective Preparations NEC, Anti-infective agents, Article, HemispheRx Biopharma

---

How old can bills be and still haunt you?

Article Abstract:

The law put's one off the hook unless prosecution begins within two years for minor offenses and for major crime like burglary or robbery the state's statute of limitations runs out after five years in the state of Pennsylvania. Most private debts like money one supposedly owe a credit card company could be enforced in court after four years.

Legal issues & crime, Government regulation (cont), Government regulation, Police Protection, Legal/Government Regulation, Robbery, Laws, regulations and rules, Prosecution

---

Similar abstracts:

• Abstracts: Populist challenge for Blanco. Health care on agenda. More than right to vote
• Abstracts: Greengate Mall going on block. Greengate Mall may have buyer. Greengate mall gets a new owner
• Abstracts: 2 city law firms may merge into largest in state. A food distributor's move is a neighborhood's win. New loan option for smaller firms
• Abstracts: An experienced builder transforms into a buyer. Greeting card firms need cheering up; stocks have sagged amid slow growth and Internet competition; Gibson and American would appreciate get-well messages from Wall Street
• Abstracts: Subsidiary may join AHERF's creditors. AHERF finds errors by auditors in '97 records. Board rebuffs CEO Sanzo's offer to quit

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.